(4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo-[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, and pharmaceutically acceptable salts thereof

• 收藏
• 分享

专利权人:

AbbVie Inc.

发明人:

Qingwei Zhang,Andrew O. Stewart,Zhiren Xia

申请号：

US13758615

公开号：

US08741899B2

申请日:

2013.02.04

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present application relates to calcium channel inhibitors comprising compounds of formula (I), formula (II), formula (III), or formula (IV),wherein L1, R1, R2, R3, R4, R5, R6, R7 and Rc are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/